Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control PatientsTerminated
NCT00151476N/AUpdated Sep 4, 2024
Sponsor: Pfizer
Familial Adenomatous Polyposis (FAP)
United States, Canada, Denmark, Spain
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple MyelomaTerminated
NCT03530683Phase 1Updated Sep 3, 2024
Sponsor: Pfizer
Lymphoma · Multiple Myeloma · Acute Myeloid Leukemia · Diffuse Large B-Cell Lymphoma
United States
Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis PatientsCompleted
NCT04071405N/AUpdated Sep 3, 2024
Sponsor: Pfizer
Ulcerative Colitis
South Korea
PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid TumorsTerminated
NCT03284723Phase 1Updated Sep 3, 2024
Sponsor: Pfizer
Breast Neoplasms
United States, Australia, Italy, Russia, South Korea +1 more
A Trial of Directly Observed and Long-term VareniclineCompleted
NCT03365362Phase 4Updated Aug 30, 2024
Sponsor: Albert Einstein College of Medicine
Tobacco Use Disorder · Opioid-use Disorder
United States
A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver DysfunctionCompleted
NCT05224609Phase 1Updated Aug 30, 2024
Sponsor: Pfizer
Moderate Hepatic Impairment · Severe Hepatic Impairment · Healthy Volunteers
United States
Avelumab for Recurrent/Metastatic Nasopharyngeal CancerTerminated
NCT02875613Phase 2Updated Aug 28, 2024
Sponsor: Assuntina Sacco, M.D.
Nasopharyngeal Cancer
United States
Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA PatientsCompleted
NCT04485325Phase 4Updated Aug 28, 2024
Sponsor: Dr. Frank Behrens
Rheumatic Arthritis
Germany
A Study to Learn About How Different Forms of the Study Medicine Called Ritlecitinib Pass the Intestines of Healthy Male Adults When Taken With or Without FoodCompleted
NCT06369454Phase 1Updated Aug 28, 2024
Sponsor: Pfizer
Healthy Volunteers
United States
Korean Post-marketing Surveillance for XeljanzCompleted
NCT02984020N/AUpdated Aug 27, 2024
Sponsor: Pfizer
Rheumatoid Arthritis · Psoriatic Arthritis
South Korea
Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With PsoriasisCompleted
NCT00563524Phase 1Updated Aug 23, 2024
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Psoriasis
United States, Canada, Hong Kong, South Africa
Real-world Treatment Patterns and Effectiveness of Palbociclib and AI TherapyCompleted
NCT04176354N/AUpdated Aug 23, 2024
Sponsor: Pfizer
Metastatic Breast Cancer
United States
Vaccine-Based Immunotherapy Regimen For NSCLC and TNBCTerminated
NCT03674827Phase 1Updated Aug 23, 2024
Sponsor: Pfizer
Non-Small Cell Lung Cancer · Triple-negative Breast Cancer
United States
A Study to Understand How the Study Medicine (PF-07081532) is Processed in People With Liver DysfunctionCompleted
NCT05478603Phase 1Updated Aug 22, 2024
Sponsor: Pfizer
Hepatic Impairment · Healthy Volunteers
United States
A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid TumorsCompleted
NCT03343054Phase 1Updated Aug 22, 2024
Sponsor: Pfizer
Neoplasms · Breast Neoplasms
Japan
Immunization To Prevent Acute COPD ExacerbationsTerminated
NCT03276754N/AUpdated Aug 19, 2024
Sponsor: Pfizer
Pneumococcal Infections · COPD
Spain
STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTSCompleted
NCT05093205Phase 1Updated Aug 19, 2024
Sponsor: Pfizer
Healthy Adults
United States
A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy AdultsCompleted
NCT05673889Phase 1Updated Aug 16, 2024
Sponsor: Pfizer
Healthy
Belgium
3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)Completed
NCT00159744Phase 3Updated Aug 15, 2024
Sponsor: Organon and Co
Bipolar Disorder
9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)Completed
NCT00143182Phase 3Updated Aug 15, 2024
Sponsor: Organon and Co
Bipolar Disorder
3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)Completed
NCT00159796Phase 3Updated Aug 15, 2024
Sponsor: Organon and Co
Bipolar Disorder
Ziprasidone in Early Onset Schizophrenia Spectrum DisordersCompleted
NCT01006551Phase 2Updated Aug 15, 2024
Sponsor: University of North Carolina, Chapel Hill
Schizophrenia
United States
Retrospective Analysis of Real World Use of Ceftazidime-avibactam in the Management of Gram Negative InfectionsCompleted
NCT04628572N/AUpdated Aug 14, 2024
Sponsor: Pfizer
Gram Negative Infections
India
Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid ArthritisCompleted
NCT00815906Phase 1Updated Aug 14, 2024
Sponsor: Pfizer
Arthritis, Rheumatoid
Japan
A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese ParticipantsCompleted
NCT05257798Phase 1Updated Aug 14, 2024
Sponsor: Pfizer
Healthy
China

Previous page Next page